HEADER TRANSCRIPTION 05-FEB-18 6CBZ TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX TITLE 2 WITH ESTRADIOL AND GRIP PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ESTROGEN RECEPTOR; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 12 GROUP A MEMBER 1; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: GRIP PEPTIDE; COMPND 17 CHAIN: C, D; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ESR1, ESR, NR3A1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM: SYNTHETIC CONSTRUCT; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 32630 KEYWDS BREAST CANCER, STEROID RECEPTOR, ESTROGEN, HORMONE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.W.FANNING,G.L.GREENE REVDAT 5 26-FEB-20 6CBZ 1 REMARK REVDAT 4 21-NOV-18 6CBZ 1 REMARK REVDAT 3 04-JUL-18 6CBZ 1 JRNL REVDAT 2 13-JUN-18 6CBZ 1 JRNL REVDAT 1 28-FEB-18 6CBZ 0 JRNL AUTH P.Y.MAXIMOV,B.ABDERRAHMAN,S.W.FANNING,S.SENGUPTA,P.FAN, JRNL AUTH 2 R.F.CURPAN,D.M.Q.RINCON,J.A.GREENLAND,S.S.RAJAN,G.L.GREENE, JRNL AUTH 3 V.C.JORDAN JRNL TITL ENDOXIFEN, 4-HYDROXYTAMOXIFEN AND AN ESTROGENIC DERIVATIVE JRNL TITL 2 MODULATE ESTROGEN RECEPTOR COMPLEX MEDIATED APOPTOSIS IN JRNL TITL 3 BREAST CANCER. JRNL REF MOL. PHARMACOL. V. 94 812 2018 JRNL REFN ESSN 1521-0111 JRNL PMID 29739819 JRNL DOI 10.1124/MOL.117.111385 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 10801 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1000232516. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10801 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 34.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX 1.9_1692 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 100 MM MGCL2, TRIS PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.31050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 305 REMARK 465 LEU A 306 REMARK 465 ALA A 307 REMARK 465 LEU A 308 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 GLU A 470 REMARK 465 GLU A 471 REMARK 465 LYS A 472 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 SER B 305 REMARK 465 LEU B 306 REMARK 465 GLU B 330 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 309 OG REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 397 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 GLN D 35 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 548 49.55 39.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 982 DISTANCE = 5.89 ANGSTROMS REMARK 525 HOH A 983 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A 984 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH A 985 DISTANCE = 6.54 ANGSTROMS REMARK 525 HOH A 986 DISTANCE = 7.02 ANGSTROMS REMARK 525 HOH B 897 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH B 898 DISTANCE = 6.57 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EST A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EST B 602 DBREF 6CBZ A 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 6CBZ B 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 6CBZ C 180 187 PDB 6CBZ 6CBZ 180 187 DBREF 6CBZ D 28 35 PDB 6CBZ 6CBZ 28 35 SEQADV 6CBZ SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 6CBZ ALA B 308 UNP P03372 LEU 308 CONFLICT SEQADV 6CBZ MET B 417 UNP P03372 CYS 417 CONFLICT SEQADV 6CBZ SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 250 SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SER SEQRES 2 A 250 ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU SEQRES 3 A 250 TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET SEQRES 4 A 250 GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS SEQRES 5 A 250 MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP SEQRES 6 A 250 LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SCH ALA SEQRES 7 A 250 TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER SEQRES 8 A 250 MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU SEQRES 9 A 250 LEU LEU ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET SEQRES 10 A 250 VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG SEQRES 11 A 250 PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS SEQRES 12 A 250 LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR SEQRES 13 A 250 PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP SEQRES 14 A 250 HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU SEQRES 15 A 250 ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN SEQRES 16 A 250 GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER SEQRES 17 A 250 HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU SEQRES 18 A 250 TYR SER MET LYS SCH LYS ASN VAL VAL PRO LEU SER ASP SEQRES 19 A 250 LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA SEQRES 20 A 250 PRO THR SER SEQRES 1 B 250 SER LEU ALA ALA SER LEU THR ALA ASP GLN MET VAL SER SEQRES 2 B 250 ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU SEQRES 3 B 250 TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET MET SEQRES 4 B 250 GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS SEQRES 5 B 250 MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP SEQRES 6 B 250 LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SCH ALA SEQRES 7 B 250 TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER SEQRES 8 B 250 MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU SEQRES 9 B 250 LEU LEU ASP ARG ASN GLN GLY LYS MET VAL GLU GLY MET SEQRES 10 B 250 VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER ARG SEQRES 11 B 250 PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS SEQRES 12 B 250 LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR SEQRES 13 B 250 PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS ASP SEQRES 14 B 250 HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU SEQRES 15 B 250 ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN SEQRES 16 B 250 GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER SEQRES 17 B 250 HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU SEQRES 18 B 250 TYR SER MET LYS CYS LYS ASN VAL VAL PRO LEU SER ASP SEQRES 19 B 250 LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA SEQRES 20 B 250 PRO THR SER SEQRES 1 C 8 ALA ILE LEU HIS ARG LEU LEU GLN SEQRES 1 D 8 ALA ILE LEU HIS ARG LEU LEU GLN MODRES 6CBZ SCH A 381 CYS MODIFIED RESIDUE MODRES 6CBZ SCH A 530 CYS MODIFIED RESIDUE MODRES 6CBZ SCH B 381 CYS MODIFIED RESIDUE HET SCH A 381 16 HET SCH A 530 15 HET SCH B 381 16 HET EST A 601 20 HET GOL B 601 14 HET EST B 602 20 HETNAM SCH S-METHYL-THIO-CYSTEINE HETNAM EST ESTRADIOL HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SCH 3(C4 H9 N O2 S2) FORMUL 5 EST 2(C18 H24 O2) FORMUL 6 GOL C3 H8 O3 FORMUL 8 HOH *511(H2 O) HELIX 1 AA1 THR A 311 GLU A 323 1 13 HELIX 2 AA2 SER A 338 LYS A 362 1 25 HELIX 3 AA3 GLY A 366 LEU A 370 5 5 HELIX 4 AA4 THR A 371 MET A 396 1 26 HELIX 5 AA5 ASP A 411 LYS A 416 1 6 HELIX 6 AA6 GLY A 420 ASN A 439 1 20 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 HIS A 474 ALA A 493 1 20 HELIX 9 AA9 THR A 496 LYS A 531 1 36 HELIX 10 AB1 SER A 537 ALA A 546 1 10 HELIX 11 AB2 THR B 311 ALA B 322 1 12 HELIX 12 AB3 SER B 338 VAL B 364 1 27 HELIX 13 AB4 GLY B 366 LEU B 370 5 5 HELIX 14 AB5 THR B 371 MET B 396 1 26 HELIX 15 AB6 ASN B 413 VAL B 418 5 6 HELIX 16 AB7 GLY B 420 ASN B 439 1 20 HELIX 17 AB8 GLN B 441 SER B 456 1 16 HELIX 18 AB9 ASP B 473 ALA B 493 1 21 HELIX 19 AC1 THR B 496 ASN B 532 1 37 HELIX 20 AC2 SER B 537 ALA B 546 1 10 HELIX 21 AC3 ILE C 181 LEU C 186 1 6 HELIX 22 AC4 ILE D 29 GLN D 35 1 7 SHEET 1 AA1 2 LEU A 402 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 408 N ALA B 405 LINK C GLU A 380 N ASCH A 381 1555 1555 1.33 LINK C GLU A 380 N BSCH A 381 1555 1555 1.33 LINK C ASCH A 381 N ALA A 382 1555 1555 1.33 LINK C BSCH A 381 N ALA A 382 1555 1555 1.33 LINK C LYS A 529 N SCH A 530 1555 1555 1.32 LINK C SCH A 530 N LYS A 531 1555 1555 1.33 LINK C GLU B 380 N ASCH B 381 1555 1555 1.32 LINK C GLU B 380 N BSCH B 381 1555 1555 1.33 LINK C ASCH B 381 N ALA B 382 1555 1555 1.33 LINK C BSCH B 381 N ALA B 382 1555 1555 1.33 SITE 1 AC1 7 MET A 343 LEU A 346 GLU A 353 ARG A 394 SITE 2 AC1 7 HIS A 524 LEU A 525 HOH A 807 SITE 1 AC2 7 PHE B 337 ASN B 407 LEU B 408 LEU B 409 SITE 2 AC2 7 LEU B 410 GLN B 414 HOH B 701 SITE 1 AC3 6 LEU B 346 GLU B 353 ARG B 394 HIS B 524 SITE 2 AC3 6 LEU B 525 HOH B 759 CRYST1 56.126 84.621 58.587 90.00 108.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017817 0.000000 0.005955 0.00000 SCALE2 0.000000 0.011817 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017997 0.00000